Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease

US9644241B2 · kind B2 · utility

Assignee

• Interpace Diagnostics Corporation · US

Inventors

• Alex Adai · Austin, US
• Anna Szafransak-Schwarzbach · Austin, US
• Bernard Andruss · Austin, US
• Stephan Hahn · Witten, DE

Key dates

• Filing date: Sep 13, 2012
• Grant date: May 9, 2017
• Expiry date: Sep 13, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/178
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.